Gland Pharma has notified the stock exchanges of its scheduled analyst and institutional investor meetings in May 2026, in compliance with Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was filed on May 18, 2026, and signed by Sampath Kumar Pallerlamudi, Company Secretary and Compliance Officer.

Upcoming Investor and Analyst Meeting Schedule

The company has outlined three meetings across different dates in May 2026, involving a mix of one-on-one and group interactions with institutional investors and analysts. The details of the scheduled meetings are as follows:

Disclosure and Compliance

The intimation has been submitted to both BSE Limited and the National Stock Exchange of India Limited in accordance with applicable listing regulations. Gland Pharma has clarified that the schedule of the above-mentioned meetings is subject to change, and any such change may occur due to exigencies on the part of the investor, analyst, or the company.

Gland Pharma Limited announced on May 14, 2026, that its shareholders have reappointed Ms. Naina Lal Kidwai (DIN: 00017806) as an Independent Director for a second consecutive term. The appointment is effective for five years from May 17, 2026, to May 16, 2031. Shareholders also approved the payment of commission on profits as remuneration to her. The decision was ratified through a remote e-voting process conducted as a postal ballot, with results verified by Scrutinizer D Soumya, Associate Partner of RVR & Associates (FCS No.: 11754; C.P No: 13199), confirming the Special Resolution was passed with the requisite majority in compliance with the Companies Act, 2013, and SEBI regulations.

Postal Ballot Overview

The Special Resolution was passed pursuant to a postal ballot notice dated April 09, 2026. The remote e-voting facility was open from April 14, 2026, to May 13, 2026, with the cut-off date for eligible shareholders set as April 10, 2026. The e-voting platform was provided by MUFG Intime India Private Limited (formerly Link Intime India Private Limited). Physical copies of the postal ballot notice and forms were not dispatched to members, in line with applicable MCA circulars permitting electronic-only communication. The Company also issued a newspaper advertisement on April 04, 2026, to facilitate members who had not yet registered their email addresses.

Voting Results

The resolution received strong shareholder support. A total of 14,94,37,703 votes were polled, representing 90.70% of the total outstanding shares. Of the votes cast, 94.18% were in favour of the reappointment, while 5.82% were against it. No invalid votes were recorded.

Category-Wise Breakdown

The Promoter and Promoter Group cast 100% of their votes in favour of the resolution. Public Institutions participated at a rate of 95.55%, with 86.42% of polled votes supporting the resolution. Public Non-Institutions had a lower participation rate of 0.06%, with 68.17% of votes in favour. The detailed category-wise breakdown is presented below.

The Scrutinizer's Report was submitted by D Soumya, Associate Partner, RVR & Associates (FCS No.: 11754; C.P No: 13199; UDIN: F011754H000363248), confirming that the Special Resolution was passed with the requisite majority. All electronic data and relevant records relating to the remote e-voting are held under the scrutinizer's custody until the Chairman approves and signs the Minutes of the Postal Ballot, after which they will be handed over to the Company Secretary for preservation.